NO and EDHF pathways in pulmonary arteries and veins are impaired in COPD patients

Vascular Pharmacology

Volumn 57, Issue 2-4, 2012, Pages 113-118

  Yang, Qin ^a   Shigemura, Norihisa ^b   Underwood, Malcolm John ^b   Hsin, Michael ^b   Xue, Hong Mei ^b   Huang, Yu ^a   He, Guo Wei ^c,e   Yu, Cheuk Man ^d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Division of Cardiothoracic Surgery   (Hong Kong)

^c NANKAI UNIVERSITY   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Chronic obstructive pulmonary disease; Endothelium; Nitric oxide; Pulmonary vasculature

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; FLURBIPROFEN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTERY ENDOTHELIUM; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ELECTROCHEMICAL ANALYSIS; ENDOTHELIAL DYSFUNCTION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LOBECTOMY; LUNG PARENCHYMA; LUNG RESECTION; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY VEIN; VASODILATATION; WESTERN BLOTTING;

AGED; BIOLOGICAL FACTORS; BLOTTING, WESTERN; DISEASE PROGRESSION; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PULMONARY ARTERY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VEINS; SEVERITY OF ILLNESS INDEX; VASODILATION;

EID: 84865405670     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.05.004     Document Type: Article

References (28)

1. Barberà J.A., Riverola A., Roca J., Ramirez J., Wagner P.D., Ros D., Wiggs B.R., Rodriguez- Roisin R. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1994, 149:423-429.
2. Barberà J.A., Peinado V.I., Santos S., Ramirez J., Roca J., Rodriguez-Roisin R. Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. Am. J. Respir. Crit. Care Med. 2001, 164:709-713.
3. Barnes P.J., Liu S.F. Regulation of pulmonary vascular tone. Pharmacol. Rev. 1995, 47:87-131.
4. Cella G., Sbarai A., Mazzaro G., Vanzo B., Romano S., Hoppensteadt T., Fareed J. Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease. Clin. Appl. Thromb. Hemost. 2001, 7:205-208.
5. Cremona G., Higenbottam T.W., Bower E.A., Wood A.M., Stewart S. Hemodynamic effects of basal and stimulated release of endogenous nitric oxide in isolated human lungs. Circulation 1999, 100:1316-1321.
6. Dinh-Xuan A.T., Higenbottam T.W., Clelland C.A., Pepke-Zaba J., Cremona G., Butt A.Y., Large S.R., Wells F.C., Wallwork J. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N. Engl. J. Med. 1991, 324:1539-1547.
7. Dinh-Xuan A.T., Pepke-Zaba J., Butt A.Y., Cremona G., Higenbottam T.W. Impairment of pulmonary-artery endothelium-dependent relaxation in chronic obstructive lung disease is not due to dysfunction of endothelial cell membrane receptors nor to l-arginine deficiency. Br. J. Pharmacol. 1993, 109:587-591.
8. Ge Z.D., Zhang X.H., Fung P.C., He G.W. Endothelium-dependent hyperpolarization and relaxation resistance to N(G)-nitro-l-arginine and indomethacin in coronary circulation. Cardiovasc. Res. 2000, 46:547-556.
9. He G.W., Liu Z.G. Comparison of nitric oxide release and endothelium-derived hyperpolarizing factor-mediated hyperpolarization between human radial and internal mammary arteries. Circulation 2001, 104:I344-I349.
10. Huang J.H., He G.W., Xue H.M., Yao X.Q., Liu X.C., Underwood M.J., Yang Q. TRPC3 channel contributes to nitric oxide release: significance during normoxia and hypoxia-reoxygenation. Cardiovasc. Res. 2011, 91:472-482.
11. Kozłowska H., Baranowska M., Schlicker E., Kozłowski M., Laudański J., Malinowska B. Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery. J. Hypertens. 2007, 25:2240-2248.
12. Lawrence R.N., Clelland C., Beggs D., Salama F.D., Dunn W.R., Wilson V.G. Differential role of vasoactive prostanoids in porcine and human isolated pulmonary arteries in response to endothelium-dependent relaxants. Br. J. Pharmacol. 1998, 125:1128-1137.
13. Liu Z.G., Ge Z.D., He G.W. Difference in endothelium-derived hyperpolarizing factor-mediated hyperpolarization and nitric oxide release between human internal mammary artery andsaphenous vein. Circulation 2000, 102:III296-III301.
14. Norel X., Walch L., Costantino M., Labat C., Gorenne I., Dulmet E., Rossi F., Brink C. M1 and M3 muscarinic receptors in human pulmonary arteries. Br. J. Pharmacol. 1996, 119:149-157.
15. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., Hurd S.S., GOLD Scientific Committee Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 2001, 163:1256-1276.
16. Peinado V.I., Barbera J.A., Ramirez J., Gomez F.P., Roca J., Jover L., Gimferrer J.M., Rodriguez-Roisin R. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am. J. Physiol. 1998, 274:L908-L913.
17. Shimokawa H., Yasutake H., Fujii K., Owada M.K., Nakaike R., Fukumoto Y., Takayanagi T., Nagao T., Egashira K., Fujishima M., Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J. Cardiovasc. Pharmacol. 1996, 28:703-711.
18. Vanhoutte P.M. Vascular biology: old-timer makes a comeback. Nature 1998, 396:213-216.
19. Voelkel N.F., Cool C.D. Pulmonary vascular involvement in chronic obstructive pulmonary disease. Eur. Respir. J. Suppl. 2003, 22:28s-32s.
20. Wright J.L., Petty T., Thurlbeck W.M. Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health nocturnal oxygen therapy trial. Lung 1992, 170:109-124.
21. Yang Q., Liu Y.C., Zou W., Yim A.P., He G.W. Protective effect of magnesium on the endothelial function mediated by endothelium-derived hyperpolarizing factor in coronary arteries during cardioplegic arrest in a porcine model. J. Thorac. Cardiovasc. Surg. 2002, 124:361-370.
22. Yang Q., Ge Z.D., Yang C.Q., Huang Y., He G.W. Bioassay of endothelium-derived hyperpolarizing factor with abolishment of nitric oxide and the role of gap junctions in the porcine coronary circulation. Drug Dev. Res. 2003, 58:99-110.
23. Yang Q., Zhang R.Z., Yim A.P., He G.W. Release of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in porcine coronary arteries exposed to hyperkalemia: effect of nicorandil. Ann. Thorac. Surg. 2005, 79:2065-2071.
24. Yang Q., Yim A.P., He G.W. The significance of endothelium-derived hyperpolarizing factor in the human circulation. Curr. Vasc. Pharmacol. 2007, 5:85-92.
25. Yang Q., Hohimer R.A., Giraud G.D., Van Winkle D.M., Underwood M.J., He G.W., Davis L.E. Effect of fetal anaemia on myocardial ischaemia-reperfusion injury and coronary vasoreactivity in adult sheep. Acta Physiol. (Oxf.) 2008, 194:325-334.
26. Yang Q., Huang J.H., Man Y.B., Yao X.Q., He G.W. Use of intermediate/small conductance calcium-activated potassium channel activator for endothelial protection. J. Thorac. Cardiovasc. Surg. 2011, 141:501-510.e1.
27. Zhang R.Z., Yang Q., Yim A.P., Huang Y., He G.W. Different role of nitric oxide and endothelium-derived hyperpolarizing factor in endothelium-dependent hyperpolarization and relaxation in porcine coronary arterial and venous system. J. Cardiovasc. Pharmacol. 2004, 43:839-850.
28. Zhang R.Z., Yang Q., Yim A.P., Huang Y., He G.W. Role of NO and EDHF-mediated endothelial function in the porcine pulmonary circulation: comparison between pulmonary artery and vein. Vascul. Pharmacol. 2006, 44:183-191.